Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Post by wintraderon Nov 09, 2020 1:16pm
146 Views
Post# 31863807

SONA antigen rapid test performs extremely well !!

SONA antigen rapid test performs extremely well !!Conclusions: 

This paper outlines evidence that Sona’s rapid antigen test performs extremely well in its ability to identify patients with the highest risk of transmission. Access and deployment of rapid tests is key to combating the current pandemic. With only a handful of such tests available, it is imperative that as many developers and manufacturers as possible can bring these to market and make them widely available in a bid to dramatically reduce community transmission rates that are currently rising as many countries enter a second wave. Rapid antigen detection tests, such as Sona’s, can be utilised as screening tools among at-risk populations to allow for infected individuals to isolate at home and therefore cut or reduce transmission chains. These diagnostic tools can be used in screening systems that identify potentially positive workers and customers from long-term care facilities, manufacturers, airlines, schools and other environments in which populations are not able to maintain social distancing in order serve their function.

https://t.co/A0N6PtGRRu?amp=1
<< Previous
Bullboard Posts
Next >>